PTF-Derived Drug Delivery System for Retinal Diseases
This innovative system offers a non-invasive method that enhances the patient experience.
Based on tissue-oriented PTF, this drug delivery system is designed to be tissue-selective, accommodating multiple drug modalities.
The system aims to deliver therapeutic molecules, such as antibodies, enzymes, transcription factors, and more, specifically targeting retinal diseases.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.